OptiNose

OPTN NASDAQ
5.94
+0.11
+1.89%
Opening 12:14 07/23 EDT
Open
5.87
Prev Close
5.83
High
6.00
Low
5.50
Volume
109.27K
Avg Vol (3M)
200.31K
52 Week High
24.55
52 Week Low
5.50
% Turnover
0.26%
Market Cap
245.11M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers OptiNose OPTN stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation.
MORE >

Recently

Name
Price
%Change